- Home
- GRVY vs SGHT Comparison
GRVY vs SGHT Comparison
Compare GRVY & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRVY | SGHT |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.1M | 395.5M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GRVY | SGHT |
|---|---|---|
| Price | $63.30 | $6.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $8.23 |
| AVG Volume (30 Days) | 17.4K | ★ 347.7K |
| Earning Date | 11-07-2025 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.02 | N/A |
| Revenue | ★ $399,496,744.00 | $76,052,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.07 |
| P/E Ratio | $7.70 | ★ N/A |
| Revenue Growth | ★ 12.13 | N/A |
| 52 Week Low | $53.12 | $2.03 |
| 52 Week High | $70.00 | $9.24 |
Technical Indicators
Market Signals| Indicator | GRVY | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 67.00 | 35.34 |
| Support Level | $59.47 | $5.96 |
| Resistance Level | $59.39 | $7.55 |
| Average True Range (ATR) | 1.93 | 0.49 |
| MACD | 0.35 | -0.16 |
| Stochastic Oscillator | 83.14 | 20.63 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.